Mapping the proteo-genomic convergence of human diseases

Maik Pietzner(University of Cambridge), Eleanor Wheeler(University of Cambridge), Julia Carrasco-Zanini(University of Cambridge), Adrián Cortés(GlaxoSmithKline (United Kingdom)), Mine Koprulu(University of Cambridge), Maria A. Wörheide(Helmholtz Zentrum München), Erin Oerton(University of Cambridge), James Cook(University of Cambridge), Isobel D. Stewart(University of Cambridge), Nicola D. Kerrison(University of Cambridge), Jian’an Luan(University of Cambridge), Johannes Raffler(University Hospital Augsburg), Matthias Arnold(Duke University), Wiebke Arlt(University of Birmingham), Stephen O’Rahilly(Wellcome/MRC Institute of Metabolic Science), Gabi Kastenmüller(Helmholtz Zentrum München), Eric R. Gamazon(University of Cambridge), Aroon D. Hingorani(British Heart Foundation), Robert A. Scott(GlaxoSmithKline (United Kingdom)), Nicholas J. Wareham(University of Cambridge), Claudia Langenberg(University of Cambridge)
Science
November 11, 2021
Cited by 638Open Access
Full Text

Abstract

Characterization of the genetic regulation of proteins is essential for understanding disease etiology and developing therapies. We identified 10,674 genetic associations for 3892 plasma proteins to create a cis-anchored gene-protein-disease map of 1859 connections that highlights strong cross-disease biological convergence. This proteo-genomic map provides a framework to connect etiologically related diseases, to provide biological context for new or emerging disorders, and to integrate different biological domains to establish mechanisms for known gene-disease links. Our results identify proteo-genomic connections within and between diseases and establish the value of cis-protein variants for annotation of likely causal disease genes at loci identified in genome-wide association studies, thereby addressing a major barrier to experimental validation and clinical translation of genetic discoveries.


Related Papers

No related papers found

Powered by citation graph analysis